Emerging Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease: From Composition to Function
- PMID: 30196156
- PMCID: PMC6314895
- DOI: 10.1016/j.cgh.2018.08.065
Emerging Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease: From Composition to Function
Abstract
The gut microbiome, a diverse microbial community in the gastrointestinal tract, plays a pivotal role in the maintenance of health. The gut microbiome metabolizes dietary and host-derived molecules to produce bioactive metabolites, which have a wide array of effects on host metabolism and immunity. 'Dysbiosis' of the gut microbiome, commonly considered as perturbation of microbiome diversity and composition, has been associated with intestinal and extra-intestinal diseases, including nonalcoholic fatty liver disease (NAFLD). A number of endogenous and exogenous factors, such as nutritional intake and xenobiotic exposure, can alter the gut microbiome. We will review the evolving methods for studying the gut microbiome and how these profiling techniques have been utilized to further our understanding of the gut microbial community composition and functional potential in the clinical spectrum of NAFLD. We will highlight microbiome-host interactions that may contribute to the pathogenesis of NAFLD, with a primary focus on mechanisms related to the metabolic output of the gut microbiome. Finally, we will discuss potential therapeutic implications of the gut microbiome in NAFLD.
Keywords: Microbiota; Nonalcoholic Fatty Liver.
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures
Similar articles
-
New insights and therapeutic implication of gut microbiota in non-alcoholic fatty liver disease and its associated liver cancer.Cancer Lett. 2019 Sep 10;459:186-191. doi: 10.1016/j.canlet.2019.114425. Epub 2019 Jun 8. Cancer Lett. 2019. PMID: 31185249 Review.
-
Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications.Aliment Pharmacol Ther. 2019 Jul;50(2):144-158. doi: 10.1111/apt.15314. Epub 2019 May 31. Aliment Pharmacol Ther. 2019. PMID: 31149745 Free PMC article. Review.
-
The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.Hepatology. 2016 Mar;63(3):764-75. doi: 10.1002/hep.28356. Epub 2016 Jan 13. Hepatology. 2016. PMID: 26600078 Free PMC article.
-
Gut-liver axis, nutrition, and non-alcoholic fatty liver disease.Clin Biochem. 2015 Sep;48(13-14):923-30. doi: 10.1016/j.clinbiochem.2015.06.023. Epub 2015 Jul 4. Clin Biochem. 2015. PMID: 26151226 Free PMC article. Review.
-
Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?Nutrients. 2019 Nov 19;11(11):2837. doi: 10.3390/nu11112837. Nutrients. 2019. PMID: 31752378 Free PMC article. Review.
Cited by
-
Understanding the Effects of Gut Microbiota Dysbiosis on Nonalcoholic Fatty Liver Disease and the Possible Probiotics Role: Recent Updates.Int J Biol Sci. 2021 Feb 8;17(3):818-833. doi: 10.7150/ijbs.56214. eCollection 2021. Int J Biol Sci. 2021. PMID: 33767591 Free PMC article. Review.
-
Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma.World J Gastroenterol. 2023 Jan 14;29(2):286-309. doi: 10.3748/wjg.v29.i2.286. World J Gastroenterol. 2023. PMID: 36687124 Free PMC article. Review.
-
Gut Microbiota and Risk of Persistent Nonalcoholic Fatty Liver Diseases.J Clin Med. 2019 Jul 24;8(8):1089. doi: 10.3390/jcm8081089. J Clin Med. 2019. PMID: 31344854 Free PMC article.
-
Changes in the gut microbiome associated with liver stiffness improvement in nonalcoholic steatohepatitis.Therap Adv Gastroenterol. 2022 May 18;15:17562848221098243. doi: 10.1177/17562848221098243. eCollection 2022. Therap Adv Gastroenterol. 2022. PMID: 35601801 Free PMC article.
-
Shared Mechanisms between Cardiovascular Disease and NAFLD.Semin Liver Dis. 2022 Nov;42(4):455-464. doi: 10.1055/a-1930-6658. Epub 2022 Aug 25. Semin Liver Dis. 2022. PMID: 36008083 Free PMC article. Review.
References
-
- Lynch SV, Pedersen O. The Human Intestinal Microbiome in Health and Disease. The New England journal of medicine 2016;375:2369–2379. - PubMed
-
- García-Lezana T, Raurell I, Bravo M, et al. Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis. Hepatology 2018;67:1485–1498. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical